Join Our Newsletter
|
Contact
|
Glossary
Facebook
Twitter
Linkedin
MENU
MENU
Latest
The Source Blog
Key Issues
Healthcare Markets
Healthcare Costs
Price Transparency
Pharmaceuticals
System Reform
Enforcement
State Action
Overview
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
About
Articles & Reports
Key Issues
All
HEALTHCARE MARKETS
- Provider Network
-- Telehealth or Telemedicine
-- Scope of Practice
-- Any Willing Provider
-- Network Adequacy
-- Tiered Network or Narrow Network
- Competition
-- Antitrust Enforcement
-- Healthcare Consolidation
-- Most Favored Nation (MFN)
-- Certificate of Need (CON)
-- Certificate of Public Advantage (COPA)
-- Anti-Steering or Anti-Tiering
-- Price Manipulation
-- Competitive Bidding
-- Trade Secret
- Rate Regulation
- ACA Marketplace
HEALTHCARE COSTS
- Cost Containment
-- Shared Savings or Right to Shop
-- Reference Pricing
-- Prior Authorization
-- Utilization Review
- Price Gouging
- Cost-Sharing or Out-of-Pocket Costs
- High Deductible Health Plan (HDHP)
- Health Savings Account (HSA) or Health Reimbursement Account (HRA)
- Benefit Design
- Provider Payment
-- Value-Based Payment
-- Bundled Payment
-- Global Payment or Global Budget
-- Capitation
-- Population-Based Payment
-- Shared Risk or Risk-Based Payment
-- Facility Fee
HEALTHCARE SYSTEM REFORM
- Single Payer or Multi-Payer
- Public Option
- Delivery Reform
- Quality or Value-Based Reform
- Managed Competition
- Accountable Care Organization (ACO)
- Medicaid Reform or Medicaid Waiver
- Affordable Care Act (ACA)
- Federal Reform Effort
PRICE AND QUALITY TRANSPARENCY
- All-Payer Claims Database (APCD)
- Gag Clause or Non-Disclosure Agreement
- Surprise Billing or Balance Billing
- Quality Measure
PHARMACEUTICALS
- Drug Pricing
- Drug Formulary
- Pharmacy Benefit Manager (PBM)
- Pharmacy Regulation
-- Clawback Restriction
- Biosimilar or Generic Competition
-- Generic Competition Block or Delay
- Therapeutic Substitution
- Medicaid Pharmaceuticals
- Medicare Part D
- 340B Drug Pricing Program
- Drug Importation
Jurisdiction
All
Federal
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
Start Date
End Date
The Commonwealth Fund
Comparing Health Insurance Reform Options: From “Building on the ACA” to Single Payer
October 16, 2019
Kaiser Family Foundation
How Will The Medicare Part D Benefit Change Under Current Law and Leading Proposals?
October 11, 2019
The Urban Institute
States Seek Greater Control, Cost-Savings by Converting to State-Based Marketplaces
October 10, 2019
ICER Institute for Clinical and Economic Review
Unsupported Price Increase Report
October 8, 2019
Health Affairs Blog
Self-Insured Employers Are Using Price Transparency To Improve Contracting With Health Care Providers: The Indiana Experience
October 7, 2019
JAMA
Waste in the US Health Care System Estimated Costs and Potential for Savings
October 7, 2019
Health Affairs Blog
Self-Insured Employers Are Using Price Transparency To Improve Contracting With Health Care Providers: The Indiana Experience
October 7, 2019
Kaiser Family Foundation
Pre-Existing Condition Prevalence for Individuals and Families
October 4, 2019
California Health Care Foundation
The Sky’s the Limit: Health Care Prices and Market Consolidation in California
October 3, 2019
New England Journal of Medicine
Affordability Boards — The States’ New Fix for Drug Pricing
October 3, 2019
Wynne Health Group
Key Provisions of Proposals on Drug Price Negotiation, Inflation Rebates, and Medicare Part D Redesign
September 27, 2019
USC-Brookings Schaeffer Initiative for Health Policy
California saw reduction in out-of-network care from affected specialties after 2017 surprise billing law
September 26, 2019
The Commonwealth Fund
What Do Americans Think About Their Health Coverage Ahead of the 2020 Election?
September 26, 2019
Health Affairs
Health Benefits In 2019: Premiums Inch Higher, Employers Respond To Federal Policy
September 25, 2019
Kaiser Family Foundation
2019 Employer Health Benefits Survey
September 25, 2019
Center for Business and Economic Research, Ball State University
Indiana has a Monopoly Problem in Healthcare; Preliminary evidence and recommendations
September 25, 2019
Next
